0001140361-18-009346.txt : 20180221 0001140361-18-009346.hdr.sgml : 20180221 20180221160812 ACCESSION NUMBER: 0001140361-18-009346 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20180219 FILED AS OF DATE: 20180221 DATE AS OF CHANGE: 20180221 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: LaRocca John CENTRAL INDEX KEY: 0001732197 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-36152 FILM NUMBER: 18628451 MAIL ADDRESS: STREET 1: C/O AERIE PHARMACEUTICALS, INC. STREET 2: 4301 EMPEROR BLVD., SUITE 400 CITY: DURHAM STATE: NC ZIP: 27703 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: AERIE PHARMACEUTICALS INC CENTRAL INDEX KEY: 0001337553 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] IRS NUMBER: 203109565 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 7020 KIT CREEK ROAD STREET 2: SUITE 270 CITY: RESEARCH TRIANGLE PARK STATE: NC ZIP: 27709 BUSINESS PHONE: 919-313-9650 MAIL ADDRESS: STREET 1: 7020 KIT CREEK ROAD STREET 2: SUITE 270 CITY: RESEARCH TRIANGLE PARK STATE: NC ZIP: 27709 4 1 doc1.xml FORM 4 X0306 4 2018-02-19 0 0001337553 AERIE PHARMACEUTICALS INC AERI 0001732197 LaRocca John C/O AERIE PHARMACEUTICALS, INC. 4301 EMPEROR BLVD., SUITE 400 DURHAM NC 27703 0 1 0 0 General Counsel Common Stock 2018-02-19 4 A 0 18000 0 A 18000 D Stock Option (Right to Buy) 54.9 2018-02-19 4 A 0 70000 0 A 2028-02-19 Common Stock 70000 70000 D These shares of Common Stock were granted under the Aerie Pharmaceuticals, Inc. Amended and Restated Inducement Award Plan (the "Plan") and are scheduled to vest, subject to the reporting person's continued employment with the issuer through the applicable vesting date, in equal installments on each of the first four anniversaries of February 19, 2018. This option was granted under the Plan and is scheduled to vest, subject to the reporting person's continued employment with the issuer through the applicable vesting date, as to 25% of the underlying shares on February 19, 2019 and as to the remaining underlying shares in substantially equal installments on each of the first 36 monthly anniversaries of February 19, 2019. /s/ John LaRocca 2018-02-21